To describe the changes of the ocular surface following chronic use of eye drop therapies. The possible pathogenetic mechanisms responsible for specific signs and symptoms are described and discussed.

Ocular surface damage by ophthalmic compounds / Mantelli, Flavio; Tranchina, Laura; Lambiase, Alessandro; Bonini, Stefano. - In: CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY. - ISSN 1528-4050. - STAMPA. - 11:5(2011), pp. 464-470. [10.1097/ACI.0b013e32834a95c9]

Ocular surface damage by ophthalmic compounds

LAMBIASE, ALESSANDRO;
2011

Abstract

To describe the changes of the ocular surface following chronic use of eye drop therapies. The possible pathogenetic mechanisms responsible for specific signs and symptoms are described and discussed.
2011
Administration, Ophthalmic; Anti-Allergic Agents; Biological Markers; Disease Susceptibility; Drug Hypersensitivity; Dry Eye Syndromes; Epithelium; Eye; Eye Diseases; Humans; Inflammation; Mucin 5AC; Ophthalmic Solutions; Preservatives, Pharmaceutical
01 Pubblicazione su rivista::01a Articolo in rivista
Ocular surface damage by ophthalmic compounds / Mantelli, Flavio; Tranchina, Laura; Lambiase, Alessandro; Bonini, Stefano. - In: CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY. - ISSN 1528-4050. - STAMPA. - 11:5(2011), pp. 464-470. [10.1097/ACI.0b013e32834a95c9]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/793299
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 40
  • ???jsp.display-item.citation.isi??? 31
social impact